# NCT04566328 (NCT04566328)

> Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04566328
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: ECOG-ACRIN Cancer Research Group
- Conditions: Plasma Cell Myeloma; RISS Stage I Plasma Cell Myeloma; RISS Stage II Plasma Cell Myeloma
- Interventions: Bortezomib; Daratumumab and Hyaluronidase-fihj; Dexamethasone; Lenalidomide; Quality-of-Life Assessment
- Enrollment: 1450
- Primary outcome: Consolidation overall survival

## Commentary we found

- X threads: 223

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct04566328

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04566328", "email": "<work email>"}; the inbox owner confirms by the emailed link.